Erratum: A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs

In the original article by Morris et al,¹ the Conflicts of Interest statement is incorrect. It should read as follows:

Meghan D. Morris received grants from Gilead Sciences. Rachel Kanner owns stock in and is an employee of Guardant Health. Jennifer C. Price received grants from Gilead Sciences, Merck, Abbvie, and Zydus Therapeutics. The remaining authors have no conflicts to report.